Identification of Folate Binding Protein of Mitochondria As Dimethylglycine Dehydrogenase (Flavoprotein/Sarcosine Dehydrogenase/Tetrahydrofolate) ARTHUR J

Total Page:16

File Type:pdf, Size:1020Kb

Identification of Folate Binding Protein of Mitochondria As Dimethylglycine Dehydrogenase (Flavoprotein/Sarcosine Dehydrogenase/Tetrahydrofolate) ARTHUR J Proc. Natl. Acad. Sci. USA Vol. 77, No. 8, pp. 4484-4488, August 1980 Biochemistry Identification of folate binding protein of mitochondria as dimethylglycine dehydrogenase (flavoprotein/sarcosine dehydrogenase/tetrahydrofolate) ARTHUR J. WITTWER* AND CONRAD WAGNERt Department of Biochemistry, Vanderbilt University and Veterans Administration Medical Center, Nashville, Tennessee 37203 Communicated by Sidney P. Colowick, April 24,1980 ABSTRACT The folate-binding protein of rat liver mito- Preparation of Tetrahydro[3H]folic Acid (H4[3HJPteGIu). chondria [Zamierowski, M. & Wagner, C. (1977) J. BioL Chem. [3',5',7,9-3H]PteGlu, potassium salt (20 Ci/mmol; 1 Ci = 3.7 252,933-9381 has been purified to homogeneity by a combina- tion of gel filtration, DEAE-cellulose, and affinity chromatog- X 101' becquerels) was obtained from Amersham. Unlabeled raphy. This protein was assayed by its ability to bind tetrahv- PteGlu (Sigma) was added to adjust the specific activity to 20 dro[3H folic acid in vitro. The purified protein contains tightly ,uCi/Amol. H4[3',5',7,9-3H]PteGlu was synthesized by chemical bound flavin and has a molecular weight of about 90,000 as reduction with NaBH4 (2). To 0.70 ml of 0.066 M Tris-HCI at determined by sodium dodecyl sulfate electrophoresis. This pH 7.8 was added 0.30 ml of a solution containing 0.40 protein also displays dimethylglycine deh drogenase [NN- ,gmol dimethylglycine: (acceptor) oxidoreductase (deme ylating), EC (8 ,Ci) of [3H]PteGlu. This solution was stirred in the dark 1.5.99.21 activity which copurifies with the folatebinding ac- under nitrogen at room temperature, and 0.25 ml of NaBH4 tivity. It is suggested that the role of the tetrahydrofolic acid is (120 mg/ml) was added. Disappearance of yellow color and a to accept the formaldehyde produced during the course of the shift of the absorption maximum from 282 nm to 296 nm (3) reaction. indicated the formation of H4PteGlu. After 45 min, the pH was adjusted to 7.5 with 5 M acetic acid, 14 ,gl of 2-mercaptoethanol Three years ago this laboratory reported the presence of a group was added, and the volume was adjusted to 2 ml with water. of cellular folate-binding proteins in rat liver (1) on the basis This solution was used, without purification, for binding assays of the incorporation of intraperitoneally administered [3H]folic and was stored under nitrogen at -20°C. Analysis of purity by acid (PteGlu) into high molecular weight forms. By using ion exchange chromatography (0.8 X 8 cm column of DEAE- chromatography on Sephadex G-150, three separate binding with 0.1 M proteins were identified in the cytosol and a fourth was found cellulose equilibrated potassium phosphate, pH in extracts of the rat liver mitochondria. Dihydrofolate re- 6;1/0.1 M 2-mercaptoethanol and eluted with 0.3 M KCI in the ductase (5,6,7,8-tetrahydrofolate:NADP+ oxidoreductase, EC equilibrating buffer) showed it to be 60-65% pure. 1.5.1.3) activity was associated with the protein from cytosol Separate experiments established that the likely contaminants having an estimated molecular weight of 25,000. None of the in this preparation, PteGlu, p-aminobenzoylglutamic acid, and other protein fractions could be shown to exhibit any of a pterin-6-carboxylic acid, did not interfere with the binding number of enzyme activities known to participate in folic acid assay at the possible levels present. metabolism. Centrifugal Desalting Procedure. Rapid desalting of small We have now succeeded in purifying the folate-binding volumes of liquid by centrifugation through small columns of protein from mitochondria to a stage of apparent homogeneity. gel filtration medium (4) has been used to measure ligand This protein was previously shown (1) to have an apparent binding to macromolecules (5). Bio-Gel P-10 (Bio-Rad) was molecular weight of 90,000 by gel filtration of the crude mi- equilibrated with buffer (10 mM potassium phosphate, pH tochondrial extract. Further purification has demonstrated that 7.0/10 mM 2-mercaptoethanol). The gel was transferred to it contains tightly bound flavin and has dimethylglycine de- small disposable plastic columns (4.5 ml screening tubes, Whale hydrogenase [N,N-dimethylglycine: (acceptor) oxidoreductase Scientific, Denver, CO) to yield 2 ml of gravity-packed gel (3 (demethylating), EC 1.5.99.2] activity. X 0.9 cm). Columns were inserted into receiving tubes (16 X 100 mm glass test tubes) and were readied for sample appli- MATERIALS AND METHODS cation by centrifugation at 620 X g for 3 min in a Sorvall GLC-1 Materials. 2-Mercaptoethanol was obtained from Eastman centrifuge. The volume of the packed gel decreased by about Kodak, 2,6-dichlorophenolindophenol and dimethylglycine 50% during this centrifugation. The columns were transferred hydrochloride were from Sigma, phenazine methosulfate was to clean receiving tubes and the sample to be desalted (about from Mann Research Laboratories (Orangeburg, NY), sarcosine 0.2 ml) was applied to the gel surface. The centrifugation was hydrochloride was from Calbiochem, DEAE-cellulose (DE-52) repeated and the desalted sample was recovered from the re- was from Whatman, and aminohexyl-Sepharose-4B was from ceiving tube. The gel columns were regenerated by washing Pharmacia. 5-Formyltetrahydrofolic acid was obtained as the twice with 1.5-ml portions of buffer. Washing was facilitated calcium salt from Lederle Laboratories (Pearl River, NY) and by centrifugation at 35 X g for 3 min. pterin-6-carboxylic acid was from Aldrich. All other chemicals were the highest grade commercially available. Abbreviations: PteGlu, pteroylglutamic acid (folic acid); H4PteGlu, 5,6,7,8-tetrahydropteroylglutamic acid (tetrahydrofolic acid). The publication costs of this article were defrayed in part by page * Present address: Section on Intermediary Metabolism and Bioener- charge payment. This article must therefore be hereby marked "ad- getics, Laboratory of Biochemistry, National Heart, Lung and Blood vertisement" in accordance with 18 U. S. C. §1734 solely to indicate Institute, National Institutes of Health, Bethesda, MD 20205. this fact. t To whom reprint requests should be addressed. 4484 Downloaded by guest on September 23, 2021 Biochemistry: Wittwer and Wagner Proc. Natl. Acad. Sci. USA 77 (1980) 4485 Folate-Binding Assay. This method utilizes the centrifugal (8), using a 9% separating gel at pH 8.8 and a 3% stacking gel desalting procedure described above. All steps except the at pH 6.8. Gels were stained in 0.05% Coomassie blue in 14% centrifugation were carried out with the receiving tubes and methanol/8% acetic acid and destained by diffusion in 10% columns chilled in an ice bath. A 10,uM solution of H4[3', methanol/10% acetic acid. 5',7,9-3H]PteGlu (20 MCi/Mmol) was prepared immediately before use by diluting a 200 AM solution with 10mM potassium RESULTS phosphate, pH 7.0/10 mM 2-mercaptoethanol; 20 Al of this Copurification of Folate-Binding Activity and Dimeth- solution was placed in each receiving tube. Protein samples (0.2 ylglycine Dehydrogenase Activity. We have previously shown ml) were applied to the gel columns and centrifuged, thus (9) that H4PteGlu and a single polyglutamate species of transferring the desalted protein into the labeled ligand. This H4PteGlu are the forms of folate found associated with the initial desalting eliminated any possible effects of buffer mitochondrial binding protein after passage through a Sepha- composition on binding. Column fractions from affinity dex G-150 column. The polyglutamate species has been iden- chromatography were desalted twice to eliminate inhibition tified as the pentaglutamate, H4PteGlu5 (unpublished data). of binding by the PteGlu used to elute the protein. After incu- It was subsequently learned that H4[3H]PteGlu would bind bation of the desalted protein with the labeled ligand for 10-20 rapidly to this protein in vitro; this formed the basis for the min (enough time to regenerate the gel columns) the incubation folate binding assay used here. By using this assay, a three-step mixture was again put through the centrifugal desalting pro- procedure for purification of this protein has been developed: cedure to remove unbound ligand. gel filtration chromatography on Sephadex G-150, DEAE- Radioactivity that was centrifuged through the column was cellulose chromatography, and affinity chromatography. De- indicative of H4PteGlu binding. Binding appeared to take place tails of the purification procedure will be published sepa- very rapidly under the conditions of the assay. Identical binding rately. was observed when the 10- to 20-min incubation period was After gel filtration chromatography on Sephadex G-150, the omitted. In other experiments, H4[3H]PteGlu was bound to material containing the binding activity was pooled, concen- protein and stored for several days at 50C in the presence of 10 trated to about 1/10th volume, and passed over a DEAE-cel- mM 2-mercaptoethanol. After dissociation by heating in a lulose column. Most of the binding activity was adsorbed to the boiling water bath in the presence of 1% sodium ascorbate, column. Elution with a gradient of 0-0.5 M KCI resulted in a >90% of the labeled material chromatographed as H4PteGlu. major peak of binding activity being eluted at a conductivity This suggests that the normally labile H4PteGlu is protected of 7 mmho. A second minor peak of binding activity was eluted from aerobic oxidation when it is bound to protein. Binding was at 16 mmho. The major peak of binding activity was pooled, proportional to the amount of sample added in the range 0-800 concentrated to about 1/10th volume, and equilibrated with dpm of recovered bound radioactivity, or up to about 10% of 0.01 M phosphate buffer at pH 7.8. This was then applied to the total label in the incubation mixture.
Recommended publications
  • Protein Identities in Evs Isolated from U87-MG GBM Cells As Determined by NG LC-MS/MS
    Protein identities in EVs isolated from U87-MG GBM cells as determined by NG LC-MS/MS. No. Accession Description Σ Coverage Σ# Proteins Σ# Unique Peptides Σ# Peptides Σ# PSMs # AAs MW [kDa] calc. pI 1 A8MS94 Putative golgin subfamily A member 2-like protein 5 OS=Homo sapiens PE=5 SV=2 - [GG2L5_HUMAN] 100 1 1 7 88 110 12,03704523 5,681152344 2 P60660 Myosin light polypeptide 6 OS=Homo sapiens GN=MYL6 PE=1 SV=2 - [MYL6_HUMAN] 100 3 5 17 173 151 16,91913397 4,652832031 3 Q6ZYL4 General transcription factor IIH subunit 5 OS=Homo sapiens GN=GTF2H5 PE=1 SV=1 - [TF2H5_HUMAN] 98,59 1 1 4 13 71 8,048185945 4,652832031 4 P60709 Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 - [ACTB_HUMAN] 97,6 5 5 35 917 375 41,70973209 5,478027344 5 P13489 Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2 - [RINI_HUMAN] 96,75 1 12 37 173 461 49,94108966 4,817871094 6 P09382 Galectin-1 OS=Homo sapiens GN=LGALS1 PE=1 SV=2 - [LEG1_HUMAN] 96,3 1 7 14 283 135 14,70620005 5,503417969 7 P60174 Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 - [TPIS_HUMAN] 95,1 3 16 25 375 286 30,77169764 5,922363281 8 P04406 Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 - [G3P_HUMAN] 94,63 2 13 31 509 335 36,03039959 8,455566406 9 Q15185 Prostaglandin E synthase 3 OS=Homo sapiens GN=PTGES3 PE=1 SV=1 - [TEBP_HUMAN] 93,13 1 5 12 74 160 18,68541938 4,538574219 10 P09417 Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 - [DHPR_HUMAN] 93,03 1 1 17 69 244 25,77302971 7,371582031 11 P01911 HLA class II histocompatibility antigen,
    [Show full text]
  • Sarcosine and Other Metabolites Along the Choline Oxidation Pathway in Relation to Prostate Cancer—A Large Nested Case–Control Study Within the JANUS Cohort in Norway
    IJC International Journal of Cancer Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer—A large nested case–control study within the JANUS cohort in Norway Stefan de Vogel1, Arve Ulvik2, Klaus Meyer2, Per Magne Ueland3,4, Ottar Nyga˚rd5,6, Stein Emil Vollset1,7, Grethe S. Tell1, Jesse F. Gregory III8, Steinar Tretli9 and Tone Bjïrge1,7 1 Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway 2 BEVITAL AS, Bergen, Norway 3 Section for Pharmacology, Institute of Medicine, University of Bergen, Bergen, Norway 4 Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway 5 Section for Cardiology, Institute of Medicine, University of Bergen, Bergen, Norway 6 Department of Heart Disease, Haukeland University Hospital, Bergen, Norway 7 Norwegian Institute of Public Health, Bergen, Norway 8 Food Science and Human Nutrition Department, University of Florida, Gainesville, FL 9 The Cancer Registry of Norway, Oslo, Norway Methyl group donors and intermediates of one-carbon metabolism affect DNA synthesis and DNA methylation, and may thereby affect prostate carcinogenesis. Choline, the precursor of betaine, and the one-carbon metabolite sarcosine have been associated with increased prostate cancer risk. Within JANUS, a prospective cohort in Norway (n 5 317,000) with baseline serum samples, we conducted a nested case–control study among 3,000 prostate cancer cases and 3,000 controls. Using conditional logistic regression, odds ratios (ORs) and 95% confidence intervals (CIs) for prostate cancer risk were estimated according to quintiles of circulating betaine, dimethylglycine (DMG), sarcosine, glycine and serine. High sarcosine and glycine concentrations were associated with reduced prostate cancer risk of borderline significance (sarcosine: highest vs.
    [Show full text]
  • Proton NMR Spectroscopic Analysis of Multiple Acyl-Coa Dehydrogenase Deficiencyðcapacity of the Choline Oxidation Pathway for Methylation in Vivo
    Biochimica et Biophysica Acta 1406Ž. 1998 274±282 View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Proton NMR spectroscopic analysis of multiple acyl-CoA dehydrogenase deficiencyÐcapacity of the choline oxidation pathway for methylation in vivo Shamus P. Burns a, Heather C. Holmes a, Ronald A. Chalmers c, Andrew Johnson b, Richard A. Iles a,) a Medical Unit, Cellular and Molecular Mechanisms Research Group, St. Bartholomew's and The Royal London School of Medicine and Dentistry, Whitechapel, London E1 1BB, UK b Biochemistry Unit, Institute of Child Health, London WC1N 1EH, UK c Paediatric Metabolism Unit, Department of Child Health, St. George's Hospital Medical School, London SW17 ORE, UK Received 20 January 1998; accepted 16 February 1998 Abstract Proton NMR spectra of urine from subjects with multiple acyl-CoA dehydrogenase deficiency, caused by defects in either the electron transport flavoprotein or electron transport flavoprotein ubiquinone oxidoreductase, provide a characteris- tic and possibly diagnostic metabolite profile. The detection of dimethylglycine and sarcosine, intermediates in the oxidative degradation of choline, should discriminate between multiple acyl-CoA dehydrogenase deficiency and related disorders involving fatty acid oxidation. The excretion rates of betaine, dimethylglycineŽ. and sarcosine in these subjects give an estimate of the minimum rates of both choline oxidation and methyl group release from betaine and reveal that the latter is comparable with the calculated total body methyl requirement in the human infant even when choline intake is very low. Our results provide a new insight into the rates of in vivo methylation in early human development.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Differential Gene Expression in Tomato Fruit and Colletotrichum
    Barad et al. BMC Genomics (2017) 18:579 DOI 10.1186/s12864-017-3961-6 RESEARCH Open Access Differential gene expression in tomato fruit and Colletotrichum gloeosporioides during colonization of the RNAi–SlPH tomato line with reduced fruit acidity and higher pH Shiri Barad1,2, Noa Sela3, Amit K. Dubey1, Dilip Kumar1, Neta Luria1, Dana Ment1, Shahar Cohen4, Arthur A. Schaffer4 and Dov Prusky1* Abstract Background: The destructive phytopathogen Colletotrichum gloeosporioides causes anthracnose disease in fruit. During host colonization, it secretes ammonia, which modulates environmental pH and regulates gene expression, contributing to pathogenicity. However, the effect of host pH environment on pathogen colonization has never been evaluated. Development of an isogenic tomato line with reduced expression of the gene for acidity, SlPH (Solyc10g074790.1.1), enabled this analysis. Total RNA from C. gloeosporioides colonizing wild-type (WT) and RNAi– SlPH tomato lines was sequenced and gene-expression patterns were compared. Results: C. gloeosporioides inoculation of the RNAi–SlPH line with pH 5.96 compared to the WT line with pH 4.2 showed 30% higher colonization and reduced ammonia accumulation. Large-scale comparative transcriptome analysis of the colonized RNAi–SlPH and WT lines revealed their different mechanisms of colonization-pattern activation: whereas the WT tomato upregulated 13-LOX (lipoxygenase), jasmonic acid and glutamate biosynthesis pathways, it downregulated processes related to chlorogenic acid biosynthesis II, phenylpropanoid biosynthesis and hydroxycinnamic acid tyramine amide biosynthesis; the RNAi–SlPH line upregulated UDP-D-galacturonate biosynthesis I and free phenylpropanoid acid biosynthesis, but mainly downregulated pathways related to sugar metabolism, such as the glyoxylate cycle and L-arabinose degradation II.
    [Show full text]
  • Phosphine Stabilizers for Oxidoreductase Enzymes
    Europäisches Patentamt *EP001181356B1* (19) European Patent Office Office européen des brevets (11) EP 1 181 356 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.7: C12N 9/02, C12P 7/00, of the grant of the patent: C12P 13/02, C12P 1/00 07.12.2005 Bulletin 2005/49 (86) International application number: (21) Application number: 00917839.3 PCT/US2000/006300 (22) Date of filing: 10.03.2000 (87) International publication number: WO 2000/053731 (14.09.2000 Gazette 2000/37) (54) Phosphine stabilizers for oxidoreductase enzymes Phosphine Stabilisatoren für oxidoreduktase Enzymen Phosphines stabilisateurs des enzymes ayant une activité comme oxidoreducase (84) Designated Contracting States: (56) References cited: DE FR GB NL US-A- 5 777 008 (30) Priority: 11.03.1999 US 123833 P • ABRIL O ET AL.: "Hybrid organometallic/enzymatic catalyst systems: (43) Date of publication of application: Regeneration of NADH using dihydrogen" 27.02.2002 Bulletin 2002/09 JOURNAL OF THE AMERICAN CHEMICAL SOCIETY., vol. 104, no. 6, 1982, pages 1552-1554, (60) Divisional application: XP002148357 DC US cited in the application 05021016.0 • BHADURI S ET AL: "Coupling of catalysis by carbonyl clusters and dehydrigenases: (73) Proprietor: EASTMAN CHEMICAL COMPANY Redution of pyruvate to L-lactate by dihydrogen" Kingsport, TN 37660 (US) JOURNAL OF THE AMERICAN CHEMICAL SOCIETY., vol. 120, no. 49, 11 October 1998 (72) Inventors: (1998-10-11), pages 12127-12128, XP002148358 • HEMBRE, Robert, T. DC US cited in the application Johnson City, TN 37601 (US) • OTSUKA K: "Regeneration of NADH and ketone • WAGENKNECHT, Paul, S. hydrogenation by hydrogen with the San Jose, CA 95129 (US) combination of hydrogenase and alcohol • PENNEY, Jonathan, M.
    [Show full text]
  • Of Drug 45, 142, 144, 346, 414 ACE Inhibitors 1
    479 Index a –– voltage-gated ion channel state Abl inhibition 359 transitions 297, 298 absorption, distribution, metabolism, and – prolongation 298 elimination (ADME), of drug 45, 142, 144, – simulated cardiac, in M cells 297, 299, 300 346, 414 – simulations 303, 304, 320 ACE inhibitors 10, 12 – stratification of AP timings 301 acetaminophen 176, 374 – supra-AP timescales 300 – inhibitors, protects against hepatotoxicity – waveform 298, 304 in vivo 376 activity-based protein profiling (ABPP) 390 – liver damage 125 acute coronary syndrome (ACS) 281, 331, – overdose 110 337 acetylation 89 acute liver injury (ALI) 88, 96, 110, 115–118, acetylators 89 120 acetylcysteine (AC) 110, 113, 115 acute lymphoblastic leukemia (ALL) 332, 333, acetylhydrazine 89 377, 401 acetyl isoniazid 89 acylcarnitines 112, 115, 116 acne 341, 342, 344, 380, 458 administration route, of drugs 52, 53 action potential 258 α2 adrenergic receptor (α2 AR) 22 – AP/QT prolongation adrenergic receptor antagonists 10 –– as a torsadogenicity biomarker 320 β-adrenergic receptors (β-ADRs) 35, 235 – duration 304 adrenocorticotropic hormone (ACTH) – estimation of proarrhythmic hERG 465 occupancy levels based on 304 ADRs. See adverse drug reactions (ADRs) –– nontrappable blockers 305 adverse drug reactions (ADRs) 3, 4, 6–8, 14, 15, –– trappable blockers 304 457 – isomorphic lengthening 298 – as a drug-induced disease 30 – normal AP and proarrhythmic – as drug-induced diseases 29 abnormalities 296 – multiscale models of 30, 31 –– abnormal calcium channel reopening – primary toxicity
    [Show full text]
  • Phylogeny and Evolution of Aldehyde Dehydrogenase-Homologous Folate Enzymes
    Chemico-Biological Interactions 191 (2011) 122–128 Contents lists available at ScienceDirect Chemico-Biological Interactions journal homepage: www.elsevier.com/locate/chembioint Phylogeny and evolution of aldehyde dehydrogenase-homologous folate enzymes Kyle C. Strickland a, Roger S. Holmes b, Natalia V. Oleinik a, Natalia I. Krupenko a, Sergey A. Krupenko a,∗ a Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC 29425 USA b School of Biomolecular and Physical Sciences, Griffith University, Nathan 4111 Brisbane, Queensland, Australia article info abstract Article history: Folate coenzymes function as one-carbon group carriers in intracellular metabolic pathways. Folate- Available online 6 January 2011 dependent reactions are compartmentalized within the cell and are catalyzed by two distinct groups of enzymes, cytosolic and mitochondrial. Some folate enzymes are present in both compartments Keywords: and are likely the products of gene duplications. A well-characterized cytosolic folate enzyme, FDH Folate metabolism (10-formyltetrahydro-folate dehydrogenase, ALDH1L1), contains a domain with significant sequence Mitochondria similarity to aldehyde dehydrogenases. This domain enables FDH to catalyze the NADP+-dependent 10-Formyltetrahydrofolate dehydrogenase conversion of short-chain aldehydes to corresponding acids in vitro. The aldehyde dehydrogenase-like Aldehyde dehydrogenase Domain structure reaction is the final step in the overall FDH mechanism, by which a tetrahydrofolate-bound formyl group + Evolution is oxidized to CO2 in an NADP -dependent fashion. We have recently cloned and characterized another folate enzyme containing an ALDH domain, a mitochondrial FDH. Here the biological roles of the two enzymes, a comparison of the respective genes, and some potential evolutionary implications are dis- cussed.
    [Show full text]
  • Supplementary Table S1 List of Proteins Identified with LC-MS/MS in the Exudates of Ustilaginoidea Virens Mol
    Supplementary Table S1 List of proteins identified with LC-MS/MS in the exudates of Ustilaginoidea virens Mol. weight NO a Protein IDs b Protein names c Score d Cov f MS/MS Peptide sequence g [kDa] e Succinate dehydrogenase [ubiquinone] 1 KDB17818.1 6.282 30.486 4.1 TGPMILDALVR iron-sulfur subunit, mitochondrial 2 KDB18023.1 3-ketoacyl-CoA thiolase, peroxisomal 6.2998 43.626 2.1 ALDLAGISR 3 KDB12646.1 ATP phosphoribosyltransferase 25.709 34.047 17.6 AIDTVVQSTAVLVQSR EIALVMDELSR SSTNTDMVDLIASR VGASDILVLDIHNTR 4 KDB11684.1 Bifunctional purine biosynthetic protein ADE1 22.54 86.534 4.5 GLAHITGGGLIENVPR SLLPVLGEIK TVGESLLTPTR 5 KDB16707.1 Proteasomal ubiquitin receptor ADRM1 12.204 42.367 4.3 GSGSGGAGPDATGGDVR 6 KDB15928.1 Cytochrome b2, mitochondrial 34.9 58.379 9.4 EFDPVHPSDTLR GVQTVEDVLR MLTGADVAQHSDAK SGIEVLAETMPVLR 7 KDB12275.1 Aspartate 1-decarboxylase 11.724 112.62 3.6 GLILTLSEIPEASK TAAIAGLGSGNIIGIPVDNAAR 8 KDB15972.1 Glucosidase 2 subunit beta 7.3902 64.984 3.2 IDPLSPQQLLPASGLAPGR AAGLALGALDDRPLDGR AIPIEVLPLAAPDVLAR AVDDHLLPSYR GGGACLLQEK 9 KDB15004.1 Ribose-5-phosphate isomerase 70.089 32.491 32.6 GPAFHAR KLIAVADSR LIAVADSR MTFFPTGSQSK YVGIGSGSTVVHVVDAIASK 10 KDB18474.1 D-arabinitol dehydrogenase 1 19.425 25.025 19.2 ENPEAQFDQLKK ILEDAIHYVR NLNWVDATLLEPASCACHGLEK 11 KDB18473.1 D-arabinitol dehydrogenase 1 11.481 10.294 36.6 FPLIPGHETVGVIAAVGK VAADNSELCNECFYCR 12 KDB15780.1 Cyanovirin-N homolog 85.42 11.188 31.7 QVINLDER TASNVQLQGSQLTAELATLSGEPR GAATAAHEAYK IELELEK KEEGDSTEKPAEETK LGGELTVDER NATDVAQTDLTPTHPIR 13 KDB14501.1 14-3-3
    [Show full text]
  • The Effect of Tetrahydrofolate on the Reduction of Electron Transfer Flavoprotein by Sarcosine and Dimethylglycine Dehydrogenases
    Biochem. J. (1982) 203, 707-715 707 Printed in Great Britain The effect of tetrahydrofolate on the reduction of electron transfer flavoprotein by sarcosine and dimethylglycine dehydrogenases Daniel J. STEENKAMP and Mazhar HUSAIN Molecular Biology Division, Veterans Administration Medical Centre, San Francisco, CA 94121 and Department ofBiochemistry and Biophysics, University ofCalifornia, San Francisce, CA 94143, U.S.A. (Received 7 December 1981/Accepted 23 February 1982) Pig liver electron transfer flavoprotein (ETF) is rapidly reduced by sarcosine and dimethylglycine dehydrogenases to the anionic semiquinone form, the subsequent formation of the flavoquinol form being a much slower process. In the presence of tetrahydrofolate the yield of anionic semiquinone at the end of the rapid phase of reduction of ETF is only about 10% less than without tetrahydrofolate, as judged by e.p.r. spectroscopy. Tetrahydrofolate does not alter the rate of reduction of ETF by either sarcosine or dimethylglycine dehydrogenase. Nevertheless, it was clearly demon- strated that tetrahydrofolate is a substrate for both sarcosine and dimethylglycine dehydrogenases and is converted to N',10-methylenetetrahydrofolate. Sarcosine and dimethylglycine dehydrogenases creased incorporation of radioactivity from the (EC 1.5.99.1 and 1.5.99.2) are flavoproteins which N-methyl group of sarcosine into serine, sarcosine catalyse the oxidative N-demethylation of sarcosine oxidase activity was unaffected (Dac & Wriston, and dimethylglycine (MacKenzie & Abeles, 1956; 1958),
    [Show full text]
  • Studies of TRIMETHYLGLYCINE OR BETAINE
    Studies of TRIMETHYLGLYCINE OR BETAINE GENERAL DESCRIPTION Trimethylglycine or Betaine ( Betaine is also called Betaine but we do not use this name because we can confuse it with Betaine Chloride; this is a strong acidifier that is taken only at mealtimes, and may cause gastric irritation ), extracted from sugar beets, is obtained from pure molasses, and separated by chromatography; it is a powerful methylating agent and plays a particularly important role in the process of detoxification of homocysteine ( a powerful oxidant and free radical generator ), which, as known, is one of the major cause of heart and vascular diseases. Recent American studies have shown the value and effectiveness of T. as a dietary supplement that can give the following benefits: - Adjuvant in cardiovascular disease - Adjuvant in sporting competitions - Adjuvant in liver diseases - Adjuvant in baldness - Adjuvant in depression - Adjuvant in hepatitis - Adjuvant in alcohol-induced hepatitis fatty liver - Adjuvant in chronic general fatigue - Increasing S-adenosyl-methionine levels - Conflicting arteriosclerosis - Decreasing apopletic stroke risk - Decreasing fat tissue amount - Improving glucose metabolism - Improving dry mouth - Improving homocisteinuria which does not respond to pyridoxine improving use of oxygen - Improving oxygen utilization - Reducing triglycerides levels in liver - Reducing Cholesterol - Reducing liver lipidosis - Useful for immune deficiency deficit (immunomodulating) - Useful for hyperhomocysteinemia STRUCTURE AND PROPERTIES From a structural standpoint, T. differs from dimethylglycine in presence of a third methyl group (CH3). T. operates very successfully in methylation or trans-methylation process, which is the process by which methyl groups (CH3) are transferred from one molecule to another; it is a biochemical process essential to life, health and regeneration of body cells.
    [Show full text]
  • Genetic Manipulation of Glycine Decarboxylation
    Journal of Experimental Botany, Vol. 54, No. 387, pp. 1523±1535, June 2003 DOI: 10.1093/jxb/erg171 REVIEW ARTICLE Genetic manipulation of glycine decarboxylation Hermann Bauwe1 and UÈ ner Kolukisaoglu Abteilung P¯anzenphysiologie der UniversitaÈt Rostock, Albert-Einstein-Strasse 3, D-18051 Rostock, Germany Received 2 October 2002; Accepted 11 March 2003 Downloaded from https://academic.oup.com/jxb/article/54/387/1523/540368 by guest on 26 September 2021 Abstract complex that occurs in all organisms, prokaryotes and eukaryotes. GDC, together with serine hydroxymethyl- The glycine±serine interconversion, catalysed by gly- transferase (SHMT), is responsible for the inter-conversion cine decarboxylase and serine hydroxymethyltransfer- of glycine and serine, an essential and ubiquitous step of ase, is an important reaction of primary metabolism in primary metabolism. In Escherichia coli, 15% of all all organisms including plants, by providing one-car- carbon atoms assimilated from glucose are estimated to bon units for many biosynthetic reactions. In plants, pass through the glycine±serine pathway (Wilson et al., in addition, it is an integral part of the photorespira- 1993). In eukaryotes, GDC is present exclusively in the tory metabolic pathway and produces large amounts mitochondria, whereas isoforms of SHMT also occur in the of photorespiratory CO within mitochondria. 2 cytosol and, in plants, in plastids. The term `glycine±serine Although controversial, there is signi®cant evidence that this process, by the relocation of glycine decar- interconversion' might suggest that the central importance boxylase within the leaves from the mesophyll to the of this pathway is just the synthesis of serine from glycine and vice versa.
    [Show full text]